Medicine shortage: AfD demands immediate solutions for the crisis!

Medicine shortage: AfD demands immediate solutions for the crisis!

The discussion about the supply of drugs in Germany has gained sharpness in the past few weeks, especially due to bottlenecks in important medication. The AfD parliamentary group has made an application to emphasize that the situation of basic medical care is acute. The parliamentary group leader Dr. Martin Vincentz was concerned about the current delivery bottlenecks and called for an immediate parliamentary debate to find solutions and to restore the security of supply for vital drugs.

In his speech, Vincentz also turned to the federal level. In his view, the countries would have to be used to make use of exemptions as soon as supply bottlenecks are found. He also emphasized the need to bring active ingredients back to Europe in order to make the German market more attractive and at the same time create jobs.

Current challenges in pharmaceutical supply

Marco Schmitz from the CDU pointed out the essential role of the saline solution for medical care. He stated that the disorder of the global supply chains must be regarded as a systemic problem and asked the federal government to use existing regulations to facilitate imports. While there are emergency solutions, long -term structural change is necessary to reduce the dependence on deliveries outside of Europe.

The lack of saline solution is a global problem, as SPD politician Thorsten Klute noted. He criticized the AfD for its unrestricted criticism of the federal government and explained that a realistic view of the situation was necessary. The focus must be on the expansion of pharmaceutical production in Europe, even if this is a long way.

Sterile saline solution is an indispensable means for many clinics. Susanne Schneider from the FDP said that this is required in many medical processes, such as operations or the dilution of painkillers. She dared to make the statement that the strict rules of the CDU-led EU Commission for the production of sterile medical devices make a contribution to the bottlenecks, since they are no longer economically feasible for many companies.

Despite the alarming reports on delivery bottlenecks, Meral Thoms von the Greens gave the all -clear that there are currently only delivery bottlenecks, but not supply bottlenecks. Nevertheless, it is essential to strengthen resources and reduce the dependence on global supply chains. The state government has already undertaken to work on a more stable supply together with the EU and the federal government.

Health Minister Karl-Josef Laumann (CDU) pointed out that challenges in medication are not a new topic. He demanded that an honest discussion not only had to be conducted through the security of the care, but also through the financing. A repayment of drug production to Europe could lead to higher prices, which could ultimately mean that the healthcare costs cost and may be required to increase health and nursing insurance contributions.

The entire discourse shows how urgent the topic is and what far -reaching the decision -makers have to consider in order to ensure basic medical care in Germany. Further information and detailed analyzes are on www.landtag.nrw.de to find.